Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BonEnza: Enzalutamide +/- Zoledronic Acid in mHSPC
NCT03336983Phase 2Completed
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Dec 2017
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in prostate cancer (PCa), bone metastases, sponsored by ASST Spedali Civili di Brescia. Started Dec 2017; status: completed.
02
Drugs
zoledronic acid
03
Conditions
prostate cancer (PCa)bone metastases
Beyond the preview
Go deeper on NCT03336983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336983.